Prana announces Share Purchase Plan Closed

Melbourne – 03 May, 2013; Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) is pleased to advise that its Share Purchase Plan (SPP) closed on Friday 26 April 2013 at 5.00 pm (EST) with applications received for 10,370,488 ordinary shares (New Shares).

Allotment of the New Shares occurred today, 3 May 2013.
Holding Statements will be mailed to shareholders on Wednesday, 8 May 2013.

Applicants are cautioned about trading in the New Shares applied for under the SPP until holding statements are received confirming the allotment of the New Shares.

Funds raised by the offer will be used to advance the development of the Company’s key clinical asset, PBT2, which is currently in two concurrent clinical trials in Huntington’s Disease and Alzheimer’s Disease.

The Board appreciates the on-going support from shareholders who have participated in the SPP.